Development Of New Universal Platform For Cancer Immunotherapy

Researchers from the Perelman School of Medicine at the University of Pennsylvania report this month in Cancer Research a universal approach to personalized cancer therapy based on T cells. It is the first time a system for making an adaptable, engineered T-cell to attack specific tumor types has been proposed, depending on which abnormal proteins, called antigens, are expressed by individual patients' tumor cells...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/B-Vr3e8n4lo/242540.php

sport sport medical sport news